Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics

Completed

• Conditions: Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease

• Registration Number: NCT05550805
• Lead Sponsor: Qilu Hospital of Shandong University

Brief Summary

To investigate whether there were differences in metabolomics and lipidomics in patients with coronary artery disease who had major adverse cardiovascular events during follow-up compared with those who did not.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-11-01
• Primary Completion: 2022-03-01
• Study Completion: 2022-03-01
• Status Verified: 2022-09
• Study First Submitted: 2022-09-20
• Study First Submitted QC: 2022-09-20
• Last Update Submitted: 2022-09-20
• Study First Posted: 2022-09-22
• Last Update Posted: 2022-09-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 666

Inclusion Criteria

1. Hospitalized patients with the diagnosis of any type of coronary artery disease;
2. Age ≥18 years of age;
3. Patient or guardian provided informed written consent.

Exclusion Criteria

1. Prior surgery, trauma or clinically evident coagulopathic bleeding within the previous 2 weeks;
2. Bipass population with missing follow-up records in Qilu Hospital emergency follow-up cohort.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
major adverse cardiovascular events	20191101-20220701	cardiac death, myocardial infarction, heart failure, stroke

Trial Locations

Locations (1)

Yuguo Chen; 🇨🇳 Jinan, Shandong, China